ES359336A1 - Procedimiento para la obtencion de una composicion a base de sulfato de estrona. - Google Patents

Procedimiento para la obtencion de una composicion a base de sulfato de estrona.

Info

Publication number
ES359336A1
ES359336A1 ES359336A ES359336A ES359336A1 ES 359336 A1 ES359336 A1 ES 359336A1 ES 359336 A ES359336 A ES 359336A ES 359336 A ES359336 A ES 359336A ES 359336 A1 ES359336 A1 ES 359336A1
Authority
ES
Spain
Prior art keywords
salts
physiologically compatible
sulphate
compatible salt
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES359336A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck KGaA
Original Assignee
E Merck AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19671617654 external-priority patent/DE1617654A1/de
Application filed by E Merck AG filed Critical E Merck AG
Publication of ES359336A1 publication Critical patent/ES359336A1/es
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/566—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol having an oxo group in position 17, e.g. estrone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ES359336A 1967-10-19 1968-10-19 Procedimiento para la obtencion de una composicion a base de sulfato de estrona. Expired ES359336A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19671617654 DE1617654A1 (de) 1967-10-19 1967-10-19 Arzneimittel

Publications (1)

Publication Number Publication Date
ES359336A1 true ES359336A1 (es) 1970-07-01

Family

ID=5682283

Family Applications (1)

Application Number Title Priority Date Filing Date
ES359336A Expired ES359336A1 (es) 1967-10-19 1968-10-19 Procedimiento para la obtencion de una composicion a base de sulfato de estrona.

Country Status (9)

Country Link
US (1) US3639599A (es)
BE (1) BE722511A (es)
BR (1) BR6803213D0 (es)
DK (1) DK120812B (es)
ES (1) ES359336A1 (es)
FR (1) FR7983M (es)
GB (1) GB1175468A (es)
IL (1) IL30594A (es)
SE (1) SE365408B (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4145416A (en) * 1976-06-23 1979-03-20 Schering, A.G. Novel agents and novel methods for treatment of climacteric disturbances
DE2645307A1 (de) * 1976-10-05 1978-04-06 Schering Ag Neue mittel und neue methoden zur behandlung klimakterischer ausfallerscheinungen
US4390531A (en) * 1981-08-10 1983-06-28 Syntex Pharmaceuticals International Ltd. Method of contraception using peak progestogen dosage
JPH0621072B2 (ja) * 1986-11-12 1994-03-23 呉羽化学工業株式会社 エストラジオ−ル誘導体よりなる免疫調節剤
US4946679A (en) * 1988-07-25 1990-08-07 Thys Jacobs Susan Method for the treatment of premenstrual syndrome
US5354743A (en) * 1992-09-15 1994-10-11 Thys Jacobs Susan Method for the treatment of premenstrual syndrome with vitamin D
WO2002078682A2 (en) * 2001-03-16 2002-10-10 Wyeth Estrogen replacement therapy
US20060040904A1 (en) * 2004-08-17 2006-02-23 Ahmed Salah U Vaginal cream compositions, kits thereof and methods of using thereof
EP1971325A2 (en) * 2005-12-27 2008-09-24 Duramed Pharmaceuticals, Inc. Conjugated estrogen compositions, applicators, kits, and methods of making and use thereof
WO2008100769A2 (en) * 2007-02-09 2008-08-21 Wyeth Process for selective sulfation of aromatic hydroxyl groups

Also Published As

Publication number Publication date
GB1175468A (en) 1969-12-23
DK120812B (da) 1971-07-19
IL30594A (en) 1972-05-30
SE365408B (es) 1974-03-25
IL30594A0 (en) 1968-10-24
BR6803213D0 (pt) 1973-04-26
FR7983M (es) 1970-06-08
US3639599A (en) 1972-02-01
BE722511A (es) 1969-04-18

Similar Documents

Publication Publication Date Title
ES359336A1 (es) Procedimiento para la obtencion de una composicion a base de sulfato de estrona.
MY104375A (en) Vitamin d derivatives and process for their preparation.
GB1384768A (en) Hair bleaching compositions and process
GB1359449A (en) Combination preparations
GB1344558A (en) Method for treating diseases by coenzyme a and adenosine triphosphate and composition therefor
GB1403900A (en) Pharmaceutical composition
GB1387911A (en) Pregnane acid derivatives
GB1270614A (en) Stable aqueous steroid phosphate solutions
GB1256723A (es)
GB1257907A (es)
GB1187946A (en) Dimethylbiguanide Derivative
GB1178946A (en) Bis-Triiodoisophthalamic Acid Compounds
GB1483165A (en) Pharmaceutical compositions and a process for the preparation thereof
DK325584A (da) 15,16-methylen-17alfa-pregna-4,6-dien-21-carbonsyresalte, farmaceutiske praeparater indeholdende disse samt fremgangsmaade til deres fremstilling
GB1266430A (es)
GB1289039A (es)
GB1266890A (es)
GB1235957A (en) Alkaloid derivative
GB1402085A (en) 15-hydroxy vincamine
GB1345938A (en) Benzodiazepines and process for their manufacture
Kabanov et al. Activation of Aluminum by the Cathodic Incorporation of an Alkali Metal
GB1266356A (es)
GB1192613A (en) Improvements in and relating to Laxative Compositions
GB953741A (en) Pharmaceutical anti-inflammatory compositions containing a substituted anthranilic acid
ALBERT STABILIZATION OF RECRYSTALLIZATION OF ENAMELS CONTAINING LOW AMOUNTS OF TIO 2.